The number we gave in the text was $2.3 million per US patent. And the reason we focus on US patent, because actually we've seen other calculations in the market and in the press, is that what you want to avoid when you do these calculations is distorting the number based upon the filing strategy of the company that held the patent, right? So the best way to do it, but it's not publicly-available information, is to say, what is the price per patent family? And patent family is basically the original patent application and then all the children that come from that patent application, whether they're US or non-US based. Companies don't tend to publish their patent families. So the next-best proxy for that is US patents, or if you were a non-US company, if you were a Japanese company, it would be Japanese patents. So it's not particular to US, it just we happened to be a US company. So that's the number we used in calculating the $2.3 million. And given that the Intel transaction was the much larger of the two transactions, the average for both are going to be, you know, that'll drive the number. And just to illustrate the point in terms of why using -- not using the total number of patents in calculating the average, why using that doesn’t make sense, is you had, let's talk about two different patent applications that were filed by one company and the second patent application by a second company, and the second company happened to file that same patent around the world. Company 1 got one patent, Company 2 got ten patents, both based upon the same, you know, one innovation, and they both sold their patents for $10 million. In the one instance, if you did the math based upon total patents, the one company got $1 million per US patent -- $1 million per patent and the other company got $10 million. Well, that's not really apples to apples; the best way to do it is look at the US-issued patents, and on that basis, both companies would have roughly gotten $10 million per US patent. So we're trying to sort of make people understand the best way to measure these things. It's obviously something that we're involved very heavily in patents and patent licensing and patent sales now, and I think we have a pretty good understanding how to value them. So we're just trying to get some sort of better data on that.
Jonathon Skeels – Davenport & Co.: Okay. And then I guess just lastly, can you just refresh on the, maybe the exact dates on the ITC with both the evidentiary hearing, initial determination, and then final determination in that case?